(1)慢性肾脏病史超过 3 个月；(2)GFR 下降<15ml/min；(3)在GFR下降过程中出现与肾衰竭相关的各种代谢紊乱和临床表现。（三）进入路径标准。1.第一诊断必须符合ICD-10：N18.902疾病编码。2.当患者同时具有其他疾病诊断，但在住院期间不需 要特殊处理也不影响第一诊断的临床路径流程实施时，可以进入路径。（四...
The risk factors for stage 3 or stage 4 CKD were defined by ICD-9/-10 codes. If eGFR measurements are available, the models can be applied to estimate the risk of the clinical outcomes by matching the eGFR value with the respective CKD stage and setting it as yes/no in the models ...
Methods We conducted an inverse probability-weighted analysis of10,946 CRT-eligible patients (ejection fraction <35%, QRS >120 ms,New York Heart Association functional class III/IV) with stage 3 to 5 CKD inthe National Cardiovascular Data Registry (NCDR) ICD Registry, comparingoutcomes between pat...
(1)慢性肾脏病史超过3个月; (2)GFR下降<15ml/min; (3)在GFR下降过程中出现与肾衰竭相关的各种代谢紊乱和临床表现。 〔三〕进入路径标准。 1.第—诊断必须符合ICD-10:N18.902疾病编码。 2.当患者同时具有其他疾病诊断,但在住院期间不需 要特别处理也不影响第—诊断的临床路径流程实施时,可以进入路径。 〔四...
(1)慢性肾脏病史超过 3 个月; (2)GFR下降<15ml/min; (3)在GFR下降过程中出现与肾衰竭相关的各种代谢紊乱和临床表现。 (三)进入路径标准。 1.第一诊断必须符合ICD-10:N18.902疾病编码。 2.当患者同时具有其他疾病诊断,但在住院期间不需 要特殊处理也不影响第一诊断的临床路径流程实施时,可以进入路径。 (四...
To evaluate the robustness of our definition for undiagnosed CKD, sensitivity analyses were conducted comparing a more stringent definition of CKD, as illustrated in patients with no ICD-10CN2016 codes for stage 3 or higher (sensitivity analysis 1; Supplementary Table S2), and also in patients ...